CAS No. 1474034-05-3
Batch:
Purity:99.91
Chemical Structure
Check the
Omaveloxolone (RTA-408)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
| IUPAC Name | N-[(4aS,6aR,6bS,8aR,12aS,14aR,14bS)-11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,3,4,5,6,7,8,8a,14a,14b-decahydropicen-4a-yl]-2,2-difluoropropanamide | |
|---|---|---|
| CAS Number | 1474034-05-3 | |
| Molecular Formula |
C33H44F2N2O3 |
|
| Molecular Weight (MW) | 554.71 | |
| SMILES | CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)NC(=O)C(C)(F)F)C | |
| InChIKey | RJCWBNBKOKFWNY-IDPLTSGASA-N |
Omaveloxolone (RTA-408) is a synthetic triterpenoid that acts as an activator of the cytoprotective Nrf2 transcription factor and an inhibitor of NF-kB signaling. Activation of the Nrf2 pathway enhances the expression of downstream antioxidant genes, including NQO1 and HMOX1, while inhibition of NF-kB suppresses pro-inflammatory signaling, collectively mitigating oxidative stress and cellular damage.
|
Concentration
Volume
Mass
|
|---|
Batch:
All in vitro solubility values are batch-tested experimental data (non-literature values).
| Solvent | Solubility & Note |
|---|---|
| DMSO |
100 mg/mL
(180.27 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 3 mg/mL |
| Water | Insoluble |
| DMSO |
100 mg/mL
(180.27 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 20 mg/mL |
| Water | Insoluble |
| DMSO |
100 mg/mL
(180.27 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 50 mg/mL |
| Water | Insoluble |
Q: Why does a DMSO stock precipitate in media/saline?
A: It is caused by unheated aqueous media (supersaturation), local solvent shock, or incorrect mixing sequence.
How to fix it?
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
- Omaveloxolone (RTA-408) Mechanism of Action: Keap1 Inhibition in Neuronal Cells Research
- Omaveloxolone (RTA-408) Clinical Trials
- Omaveloxolone (RTA-408) Working Concentration | Cell Culture | Treatment
- Omaveloxolone (RTA-408) Solubility in DMSO
- Omaveloxolone (RTA-408) Stock Solution
- Omaveloxolone (RTA-408) Storage
- Omaveloxolone (RTA-408) Stability
- Omaveloxolone (RTA-408) Combination Database
- Omaveloxolone (RTA-408) Molecular Weight
- Omaveloxolone (RTA-408) SMILES
- Omaveloxolone (RTA-408) Chemical Structure (2D and 3D)
- Omaveloxolone (RTA-408) IC50 for Cell-based and Cell-free Assays
- Omaveloxolone (RTA-408) Sigma (AMBH93E4C59A)? Try a better option.
- Omaveloxolone (RTA-408) MedChemExpress (HY-12212)? Try a better option.
- Omaveloxolone (RTA-408) Cayman (17854)? Try a better option.
- Omaveloxolone (RTA-408) APExBIO (B3576)? Try a better option.
- Omaveloxolone (RTA-408) SDS|MSDS
Note: Technical data last updated: Sep 1, 2026.